학술논문
Prevalence and disease predisposition of p.A91V perforin in an aged population of European ancestry.
Document Type
Report
Author
Voskoboinik I; Killer Cell Biology Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Lacaze P; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Jang HS; Immunorheumatology Laboratory, New South Wales Health Pathology, Royal North Shore Hospital, Sydney, NSW, Australia.; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, NSW, Australia.; Flinsenberg T; Killer Cell Biology Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Fernando SL; Immunorheumatology Laboratory, New South Wales Health Pathology, Royal North Shore Hospital, Sydney, NSW, Australia.; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, NSW, Australia.; Department of Medicine, The University of Sydney, Sydney, NSW, Australia.; Kerridge I; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia.; Riaz M; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Sebra R; Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY.; Sema4, a Mount Sinai Venture, Stamford, CT; and.; Thia K; Cancer Cell Death Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Noori T; Killer Cell Biology Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Schadt EE; Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY.; Sema4, a Mount Sinai Venture, Stamford, CT; and.; McNeil JJ; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Trapani JA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Cancer Cell Death Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Source
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Subject
Language
English